Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease

▴ Alzheimer's Disease
The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of individuals and their families affected by this devastating condition.

Alzheimer's disease is a devastating condition characterized by neurodegeneration and inflammation in the brain. Finding effective treatments for this complex disease has been challenging, as most existing therapies focus on targeting amyloid beta plaques and require early intervention through intravenous therapy. However, recent research has unveiled a promising new approach - nasal immunotherapy with anti-CD3 - which has shown potential in reducing inflammation and enhancing cognitive function in Alzheimer's disease.

The Breakthrough:

In a groundbreaking study published in the journal PNAS, researchers have uncovered preclinical evidence suggesting that nasal immunotherapy can offer significant benefits to individuals battling Alzheimer's disease. What sets this therapy apart is its ability to reduce inflammation and improve cognition independently of amyloid beta plaque levels.

Anti-CD3 Nasal Immunotherapy:

The novel nasal immunotherapy, referred to as anti-CD3, has shown remarkable results in Alzheimer's mouse models. The treatment involves administering anti-CD3 intranasally three times a week for five months. During this time, researchers observed a notable decrease in the activation of microglia, which are immune cells responsible for inflammation in the brain.

Improved Cognitive Function:

The positive effects of anti-CD3 immunotherapy were not limited to reduced inflammation. Treated mice exhibited enhanced cognitive function as demonstrated by improved performance in various behavioral tests, including a water maze. These improvements in cognition are a significant breakthrough, as cognitive decline is a hallmark of Alzheimer's disease.

Immune System Response:

The study also unveiled intriguing changes in gene expression patterns within the brain and an expansion of regulatory T cells, which play a crucial role in fighting diseases in the body. Importantly, all of these changes occurred independently of amyloid beta plaque levels, suggesting that this therapy targets aspects of Alzheimer's disease that have previously been challenging to address.

Promising Implications:

Corresponding author Howard L. Weiner from the Department of Neurology at Brigham and Women's Hospital in the US expressed "We provide evidence that intranasal anti-CD3 therapy can dampen microglia activation and expand T cells in a murine model of Alzheimer’s. This represents a unique approach to treating later-stage Alzheimer’s that can be applied to other inflammatory disease conditions as well."

Future Prospects:

Researchers are now planning to further investigate the potential of anti-CD3 immunotherapy in combination with anti-amyloid therapies in animal studies. This step is crucial in understanding how these treatments can work together to provide a comprehensive approach to Alzheimer's disease treatment. Ultimately, the goal is to advance this promising therapy into human clinical trials.

Building on Success:

This exciting breakthrough builds upon previous research by the same team, who explored the use of foralumab, the only fully human anti-CD3 monoclonal antibody treatment, in patients with COVID-19 and multiple sclerosis (MS). These efforts underscore the versatility of anti-CD3 immunotherapy in addressing a range of inflammatory conditions.

The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of individuals and their families affected by this devastating condition. As researchers continue to explore this innovative approach, there is optimism that it may offer a unique and effective way to combat Alzheimer's disease, while also holding promise for other inflammatory diseases. Further studies and clinical trials will shed more light on the full potential of this therapy in the fight against Alzheimer's

Tags : #alzheimer #nasal #immunotherapy #brainhealth #inflammatorydiseases #anti-CD3 #COVID19 #medicircle

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

Freedom Healthy Cooking Oils distributes Seed Ganesha Idols for an eco-friendly festival September 28, 2023
Sadar Hospital,Ranchi Extends Free Cancer Care through Ayushman Bharat Scheme: A ray of hopeSeptember 28, 2023
Dopamine and Its Impact on Your Brain, Feelings, and EmotionsSeptember 28, 2023
Ayushman Bharat-PMJAY: Transforming Healthcare for Millions in IndiaSeptember 28, 2023
Premature Greying of Hair: preventing in the Indian styleSeptember 28, 2023
Run organised to create awareness for Cerebral PalsySeptember 27, 2023
16 Visually challenged explored Skill Development and Employment opportunities in interactive session at FTCCI September 26, 2023
FUJIFILM India celebrates 125 Digital Mammography Machine Installation milestone at the 3rd edition of 'Together Against Breast Cancer' ConferenceSeptember 26, 2023
AI4Rx, the AI powered medical care platform, announces the launch of MedBeat HealthConnectSeptember 26, 2023
Foetal medicine taking rapid strides to optimise Foetal outcomes!September 26, 2023
NGOs bring access to primary health services between 0-3kms for residents of Slums under Jalpally Municipality in line with the UN SDP and Universal Health Coverage modelSeptember 26, 2023
Oliva Skin & Hair Clinic, launches its 25th Clinic in India and 7th in the city, at Dilsukhnagar!September 26, 2023
Badminton sensation Shashidhar brings honor to Telangana and India by clinching the Silver medal at the BWF World Senior Championship in Korea!September 26, 2023
5 Best Homemade Juices to Drink Every Day for a Healthier YouSeptember 26, 2023
Traditionally, men were seen as more profit-oriented in business, but now women are proving they are equally capable - Rahul Jain, a top Indian business coach.September 25, 2023
4-Year-Old Girl Gets New lease of life at American Oncology Institute (AOI) Hyderabad with Haploidentical Stem Cell Transplantation September 25, 2023
Silver Oaks International Schools to provide succor to the underprivileged through its ‘Silver Oaks Street Store’ initiative!September 25, 2023
Sri Pullela Gopichand addressing freshers at OMC, emphasised on focussing on goals to achieve success! September 25, 2023
Fall Prevention Experience Centre for the Elderly Inaugurated at LVPEISeptember 25, 2023
Your Retina, Your Responsibility: 5 Tips For Maintaining Eye HealthSeptember 25, 2023